B
Market Data
$191.95−$8.10 (−4.05%)
BIIB · Last trade
Prev Close
$200.05
Range (28d)
$195.61 – $216.63
Recent Filings
- 8-K202.6 KBBIOGEN INC.Jul 1, 4:08 PM ET·0000875045-26-000068
- 8-K247.2 KBBIOGEN INC.Jun 10, 4:54 PM ET·0000950157-26-000700
- 8-K/A197.5 KBBIOGEN INC.Jun 10, 4:49 PM ET·0000950157-26-000699
- SCHEDULE 13D/A9.1 KBApellis Pharmaceuticals, Inc.May 14, 4:36 PM ET·0000950157-26-000611
- 8-K1.1 MBBIOGEN INC.May 14, 8:31 AM ET·0001193125-26-222908
- 10-Q13.2 MBBIOGEN INC.Apr 29, 6:40 AM ET·0000875045-26-000045
- 8-K586.0 KBBIOGEN INC.Apr 29, 6:05 AM ET·0000875045-26-000042
- 39.9 KBBIOGEN INC.Apr 6, 6:11 PM ET·0000950157-26-000479
- SCHEDULE 13D764.1 KBApellis Pharmaceuticals, Inc.Apr 6, 6:08 PM ET·0000950157-26-000478
- 8-K201.8 KBBIOGEN INC.Apr 6, 6:31 AM ET·0000875045-26-000039
Insiders
10- ADELMAN BURT AEVP, Portfolio Strategy
- ALEXANDER SUSAN HEVP Chief Legal Officer
- BELZER ALANDirector
- BEST LAWRENCE CDirector
- BUCKNUM THOMAS JEVP and General Counsel
- CAPELLO JEFFREY DEVP & Chief Financial Officer
- Clancy Paul JExecutive VP and CFO
- COVINO GREGORY FVP, Chief Accounting Officer
- Cox JohnEVP Pharmaceutical Oper & Tech
- DEKKERS MARIJN EDirector
Tickers
Addresses
business
225 BINNEY STREET
CAMBRIDGE, MA, 02142
mailing
225 BINNEY STREET
CAMBRIDGE, MA, 02142
Former Names
- BIOGEN IDEC INC.2015-03-20
- BIOGEN IDEC INC2007-04-25
- IDEC PHARMACEUTICALS CORP / DE2003-11-12
- IDEC PHARMACEUTICALS CORP / CA1997-02-14